br br Renub Research study titled “Alzheimer’s Pipeline Drugs Review, Alzheimer’s Disease Drug Market & Forecast – Global Analysis” provides a comprehensive assessment of the fast-evolving, high-growth Global Alzheimer’s Disease Market. This 110 page report with 29 Figures and 11 Tables studies the Global Alzheimer’s Disease Drug Market. br br Present & Pipeline Drugs Studied in this Report br br 1. Namenda br 2. Ebixa br 3. Axura br 4. Aricept br 5. Nootropil br 6. Exelon br 7. Memary br 8. Solanezumab br 9. LuAe58054 br br This report contains 10 chapters. br br (Chapter 1): Executive Summary br br (Chapter 2): This Chapter is divided into 2 parts br br A. Alzheimer’s Disease Drug Market & Forecast data available from 2003 to 2018 br br B. Unmet Alzheimer’s Disease Drug Market & Forecast (Market Potential) data available from 2010 to 2018. (Unmet market is the potential market which could have been achieved if right drug have been introduced in the market) br br (Chapter 3): This chapter talks about drugs which has failed while in Clinical trials br br (Chapter 4): This chapter provides Market Share of Alzheimer’s Disease Drug from 2003 to 2018. All the 9 Alzheimer’s drug mentioned above have been covered in this chapter. br br (Chapter 5): This chapter talks about Alzheimer’s Drugs performance. All important drugs mentioned above past, present & future market data available from 2003 to 2018. br br (Chapter 6): Pipeline drugs (Solanezumab, LuAE58054, Gantenerumab, Crenezumab, TRx0237 (LMTX), MK-8931, ABT-126, AZD-1446) have been analyzed in this chapter. All drugs have been analyzed from 5 view points: br br A. Clinical Development Stage br B. Pipeline Drug Sales Performance br C. Recent Clinical Development br D. Different Companies Deal br E. Investment br br (Chapter 7): This chapter speaks of Alzheimer’s Drugs Company deals in four areas br br A. Strategic Alliances in Alzheimer’s Disease Drug Market br B. Licensing Agreement in Alzheimer’s Disease Drug Market br C. Collaboration Deal in Alzheimer’s Disease Drug Market br D. Merger & Acquisition in Alzheimer’s Disease Drug Market br br (Chapter 8): This chapter studies Funding in Alzheimer’s Disease Drugs Research. We have covered 5 institutes which provides fund for the research. br br A. National Institute of Health br B. Alzheimer's Association br C. Cure Alzheimer’s Fund br D. Alzheimer’s Drug Discovery Foundation br E. BrightFocus Foundation [formerly American Health Assistance Foundation (AHAF)] br br (Chapter 9): This chapter studies Growth Factors Driving the Alzheimer’s Disease Drug Market. br br (Chapter 10): This chapter studies ChallengesHindrances faced by Alzheimer’s Disease Drug Market. br br Contact Us br br Andy Hill br Sr. Manager - Publisher Relation br Sales & Marketing Div. br Renub Research br Email: info@renub.